[go: up one dir, main page]

ATE211655T1 - Iontophoresematrix - Google Patents

Iontophoresematrix

Info

Publication number
ATE211655T1
ATE211655T1 AT94114782T AT94114782T ATE211655T1 AT E211655 T1 ATE211655 T1 AT E211655T1 AT 94114782 T AT94114782 T AT 94114782T AT 94114782 T AT94114782 T AT 94114782T AT E211655 T1 ATE211655 T1 AT E211655T1
Authority
AT
Austria
Prior art keywords
matrix
iontophoresis
drug
drug reservoir
iontophoreses
Prior art date
Application number
AT94114782T
Other languages
English (en)
Inventor
Yasuyuki Suzuki
Katsumi Iga
Hiroaki Okada
Yukihiro Matsumoto
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE211655T1 publication Critical patent/ATE211655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94114782T 1993-09-22 1994-09-20 Iontophoresematrix ATE211655T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23645493 1993-09-22
JP30186093 1993-12-01
JP30951193 1993-12-09

Publications (1)

Publication Number Publication Date
ATE211655T1 true ATE211655T1 (de) 2002-01-15

Family

ID=27332369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94114782T ATE211655T1 (de) 1993-09-22 1994-09-20 Iontophoresematrix

Country Status (5)

Country Link
US (1) US6416503B1 (de)
EP (2) EP0643981B1 (de)
AT (1) ATE211655T1 (de)
CA (1) CA2132574A1 (de)
DE (1) DE69429603T2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700481A (en) * 1995-03-17 1997-12-23 Takeda Chemical Industries, Ltd. Transdermal drug delivery process
US5837281A (en) * 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
DE19517430A1 (de) * 1995-05-12 1996-11-14 Boehringer Mannheim Gmbh Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
IT1285405B1 (it) * 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
ATE255450T1 (de) * 1995-06-09 2003-12-15 Hisamitsu Pharmaceutical Co Matrix für iontophorese
EP0813887A3 (de) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. Iontophoretische Vorrichtung
KR100247558B1 (ko) * 1997-11-24 2000-05-01 김충섭 사이클로덱스트린을 이용한 이온토포레시스 개선방법
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
JP4414517B2 (ja) * 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
WO2001036039A2 (en) * 1999-11-17 2001-05-25 Novartis Ag Iontophoretic transdermal delivery of peptides
ES2239196T3 (es) * 2002-12-02 2005-09-16 Schwarz Pharma Ag Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
TW200416015A (en) * 2003-02-17 2004-09-01 Wei-Gung Wang Device for selectively generating hydrogen ions in an aqueous solution
US20060052306A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. GRAS composition for enhanced mucosal delivery of parathyroid hormone
CN101151048A (zh) 2004-05-10 2008-03-26 纳斯泰克制药公司 增强甲状旁腺激素粘膜递送的组合物和方法
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
US20060069021A1 (en) * 2004-08-13 2006-03-30 Nastech Pharmaceutical Company Inc. Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
EP1931374A2 (de) * 2005-10-06 2008-06-18 Nastech Pharmaceutical Company Inc. Pth-formulierungen und anwendungsverfahren
WO2007044375A2 (en) * 2005-10-06 2007-04-19 Nastech Pharmaceutical Company Inc. Pth formulations and methods of use
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
WO2007055279A1 (ja) 2005-11-14 2007-05-18 Teikoku Seiyaku Co., Ltd. イオントフォレーシス用製剤
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
JPWO2009044555A1 (ja) * 2007-10-04 2011-02-03 学校法人 城西大学 製剤、当該製剤を用いたワクチンの投与方法及びイオントフォレーシス装置
EP2052736A1 (de) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroidhormon-Formulierungen und ihre Verwendungen
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
JP6116246B2 (ja) 2009-08-10 2017-04-19 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー イオントフォレシスにより悪心および片頭痛を治療するための方法
EP3181190A1 (de) * 2015-12-15 2017-06-21 L'oreal Vorrichtung und verfahren für iontophorese

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
FR2238700B1 (de) 1973-07-24 1977-10-14 Takeda Chemical Industries Ltd
CS180644B2 (en) 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
US4253998A (en) 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
US4317815A (en) 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
JPS63102768A (ja) 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
WO1991015260A1 (en) * 1990-03-30 1991-10-17 Alza Corporation Device and method for iontophoretic drug delivery
CA2042994C (en) 1990-10-17 2004-08-03 J. Richard Gyory Iontophoretic delivery device
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
JPH04224770A (ja) 1990-12-26 1992-08-14 Teijin Ltd イオントフォレーシス用装置
CA2121372C (en) * 1991-12-03 2003-02-04 Ronald P. Haak Iontophoretic delivery device and power supply therefor
US5246417A (en) * 1991-12-11 1993-09-21 Alza Corporation Indicator for iontophoresis system
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
AU4399193A (en) * 1992-06-02 1993-12-30 Alza Corporation Iontophoretic drug delivery apparatus

Also Published As

Publication number Publication date
EP0643981B1 (de) 2002-01-09
CA2132574A1 (en) 1995-03-23
EP1138345A2 (de) 2001-10-04
US6416503B1 (en) 2002-07-09
DE69429603D1 (de) 2002-02-14
EP0643981A1 (de) 1995-03-22
EP1138345A3 (de) 2003-06-04
DE69429603T2 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
DE69429603D1 (de) Iontophoresematrix
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
PT1156043E (pt) Drogas que aumentam as respostas sinapticas mediadas por receptores de ampa
DE58903472D1 (de) Implantierbarer injektionskoerper.
DE3582202D1 (de) Elektrode fuer einen lebenden koerper.
DE68910867D1 (de) Matrix für die transdermale Abgabe von Arzneimitteln.
DE3874634D1 (de) Ueberzugsmaterial fuer den medizinischen gebrauch.
PT92838A (pt) Dispensing devices powered by hydrogel
HRP920667B1 (en) Application of fultripine active substance for preventing muscle deformation
ATE77077T1 (de) Metoprololsuccinat und dieses enthaltende pharmazeutische zusammensetzung.
EP0416444A3 (en) Ph buffered electrode for medical iontophoresis
DE3875025D1 (de) Calcitonin enthaltende zusammensetzung fuer die nasale verabreichung.
DK360188A (da) Laegemiddelafgivelsesorgan
DK0457849T3 (da) Klæbemiddel til elektrotransport
IT8820524A0 (it) Struttura di elettrodo particolarmente per apparecchiature elettroterapeutiche.
FI885257L (fi) Piezoelektriska nervstyrkanaler.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
DE3675738D1 (de) Elektrode fuer einen lebenden koerper.
SE8900875D0 (sv) Osteoporosis treatment
DE3877630D1 (de) Transkutane verabreichung von pharmazeutika.
DE3888053D1 (de) Implantierbare Elektrode zur Herzstimulation.
DE68905082D1 (de) Virushemmende pharmazeutische zusammensetzung.
DE59308931D1 (de) Körperelektrode
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
IT8763326V0 (it) Presidio medico per l'elettromagnetoterapia.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties